From USD 3.6B to USD 9.4B: How CRISPR Is Rapidly Rewriting Medicine, Food, and Diagnostics
In less than a decade, CRISPR has evolved from a scientific curiosity into one of the most powerful tools ever […]
In less than a decade, CRISPR has evolved from a scientific curiosity into one of the most powerful tools ever […]
Diabetes management is no longer confined to clinics, paper logs, or occasional lab visits. It has moved into people’s pockets,
Consumer Healthcare is no longer confined to hospitals, clinics, or prescription pads. It has steadily moved into homes, phones, supermarket
Gene therapy platforms have moved far beyond lab curiosity. What began as a high-risk, high-reward scientific ambition is now shaping
The global drug discovery market is not merely expanding—it is restructuring itself at a fundamental level. Valued at USD 71.96
The global drugs market is no longer just expanding; it is transforming. In 2025, the industry stands at USD 1,688.14
The global healthcare landscape is shifting from reactive treatment to proactive prevention—and consumption type vaccines are at the center of
Healthcare no longer lives only inside hospital walls. It now travels in pockets, rests on wrists, and speaks through screens.
The global human insulin market stands at a defining moment. As diabetes tightens its grip on populations across continents, insulin,
Nucleic acid drugs are transforming medicine, offering precision treatments that target diseases at their genetic roots. With innovations in RNA,